Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3)

This grant supports preclinical discovery and development of potential therapeutic Biotechnology Products and Biologics including, but not limited to, large biologic macromolecules, (e.g., proteins, antibodies, and peptides), gene-based therapies (i.e., oligonucleotide- and viral-based), cell therapies, and novel emerging therapies (e.g., microbial and microbiome therapies). 

Funding: No fixed limit 

Duration: 5 years total (UG3 limited to 2 years) 

Research Authority due dates: 10 days prior to submission

LOI (encouraged) due dates: 10.7.21, 9.1.22, 9.7.22, 9.1.23, 9.7.23, 9.1.24

Full proposal due dates: 10.8.21, 9.2.22, 9.8.22, 9.2.23, 9.8.23, 9.2.24